Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicholas J. Vogelzang
The Oral CYP17-Lyase (L) Inhibitor VT-464 in Patients With CRPC.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
Clinical Cancer Research
Cancer Research
Oncology
Effect of Radium-223 Dichloride (Ra-223) on Hospitalisation: An Analysis From the Phase 3 Randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) Trial
European Journal of Cancer
Cancer Research
Oncology
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis
Clinical Genitourinary Cancer
Oncology
Urology
Real-World Clinical Outcomes of Pazopanib Immediately Following Immunotherapy Discontinuation for the Treatment of Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin
Clinical Genitourinary Cancer
Oncology
Urology
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Kidney Cancer
1
2
›